Insulet Return on Investment 2007-2020 | PODD
Current and historical return on investment (ROI) values for Insulet (PODD) over the last 10 years.
| Insulet ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2020-03-31 | $0.05B | $0.96B | 5.21% |
| 2019-12-31 | $0.05B | $0.96B | 5.29% |
| 2019-09-30 | $0.05B | $1.14B | 5.30% |
| 2019-06-30 | $0.04B | $0.86B | 4.65% |
| 2019-03-31 | $0.03B | $0.82B | 4.30% |
| 2018-09-30 | $0.01B | $0.78B | 1.33% |
| 2018-06-30 | $0.01B | $0.76B | 0.76% |
| 2017-12-31 | $-0.01B | $0.73B | -1.44% |
| 2017-09-30 | $-0.01B | $0.42B | -2.47% |
| 2017-06-30 | $-0.01B | $0.41B | -2.51% |
| 2017-03-31 | $-0.01B | $0.40B | -2.30% |
| 2016-12-31 | $-0.01B | $0.40B | -3.69% |
| 2016-09-30 | $-0.02B | $0.39B | -7.98% |
| 2016-06-30 | $-0.04B | $0.20B | -17.64% |
| 2016-03-31 | $-0.05B | $0.20B | -22.70% |
| 2015-12-31 | $-0.05B | $0.21B | -20.94% |
| 2015-09-30 | $-0.04B | $0.23B | -14.29% |
| 2015-06-30 | $-0.02B | $0.25B | -9.19% |
| 2015-03-31 | $-0.01B | $0.26B | -5.55% |
| 2014-12-31 | $-0.01B | $0.25B | -3.61% |
| 2014-09-30 | $-0.01B | $0.25B | -4.04% |
| 2014-06-30 | $-0.02B | $0.25B | -9.81% |
| 2014-03-31 | $-0.03B | $0.24B | -10.25% |
| 2013-12-31 | $-0.03B | $0.24B | -11.97% |
| 2013-09-30 | $-0.04B | $0.24B | -16.04% |
| 2013-06-30 | $-0.03B | $0.25B | -13.23% |
| 2013-03-31 | $-0.03B | $0.24B | -17.87% |
| 2012-12-31 | $-0.04B | $0.15B | -22.54% |
| 2012-09-30 | $-0.04B | $0.15B | -24.05% |
| 2012-06-30 | $-0.04B | $0.16B | -23.89% |
| 2012-03-31 | $-0.05B | $0.18B | -24.74% |
| 2011-12-31 | $-0.04B | $0.19B | -24.23% |
| 2011-09-30 | $-0.04B | $0.19B | -25.65% |
| 2011-06-30 | $-0.04B | $0.20B | -26.98% |
| 2011-03-31 | $-0.04B | $0.13B | -26.37% |
| 2010-12-31 | $-0.04B | $0.14B | -28.94% |
| 2010-09-30 | $-0.04B | $0.13B | -29.60% |
| 2010-06-30 | $-0.05B | $0.14B | -35.25% |
| 2010-03-31 | $-0.05B | $0.14B | -44.64% |
| 2009-12-31 | $-0.06B | $0.15B | -54.72% |
| 2009-09-30 | $-0.07B | $0.10B | -80.89% |
| 2009-06-30 | $-0.08B | $0.08B | -83.77% |
| 2009-03-31 | $-0.09B | $0.10B | -78.54% |
| 2008-12-31 | $-0.09B | $0.09B | -83.18% |
| 2008-09-30 | $-0.08B | $0.12B | -69.64% |
| 2008-06-30 | $-0.07B | $0.14B | -65.47% |
| 2008-03-31 | $-0.06B | $0.09B | -57.14% |
| 2007-12-31 | $-0.05B | $0.11B | -61.02% |
| 2007-09-30 | $-0.05B | $0.12B | -76.42% |
| 2007-06-30 | $-0.04B | $0.13B | -128.24% |
| 2007-03-31 | $-0.04B | inf% | |
| 2006-12-31 | $-0.04B | inf% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $11.896B | $0.738B |
| INSULET CORPORATION is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use components with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of continuous subcutaneous insulin infusion (CSII) therapy among people with insulin-dependent diabetes. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $167.899B | 29.12 |
| Medtronic (MDT) | Ireland | $132.114B | 21.48 |
| Stryker (SYK) | United States | $73.365B | 23.81 |
| Boston Scientific (BSX) | United States | $53.161B | 24.99 |
| Baxter (BAX) | United States | $45.654B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $36.676B | 0.00 |
| Terumo (TRUMY) | Japan | $29.978B | 0.00 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $28.400B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $26.077B | 16.41 |
| ResMed (RMD) | United States | $23.266B | 36.72 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $17.849B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $14.583B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $14.566B | 66.31 |
| DiaSorin S.p.A (DSRLF) | Italy | $10.630B | 0.00 |
| Perrigo (PRGO) | Ireland | $7.466B | 13.36 |
| Quidel (QDEL) | United States | $7.350B | 57.76 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $7.281B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $6.767B | 19.08 |
| William Demant Holdings (WILYY) | Denmark | $6.670B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $6.590B | 0.00 |
| Canopy Growth (CGC) | Canada | $6.093B | 0.00 |
| Haemonetics (HAE) | United States | $5.517B | 33.14 |
| ICU Medical (ICUI) | United States | $4.159B | 30.34 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.796B | 0.00 |
| Neogen (NEOG) | United States | $3.754B | 63.59 |
| Agios Pharmaceuticals (AGIO) | United States | $3.564B | 0.00 |
| Envista Holdings (NVST) | United States | $3.366B | 0.00 |
| NuVasive (NUVA) | United States | $3.106B | 24.94 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $2.909B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.150B | 37.19 |
| TG Therapeutics (TGTX) | United States | $2.055B | 0.00 |
| AtriCure (ATRC) | United States | $1.916B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $1.428B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.366B | 0.00 |
| NanoString Technologies (NSTG) | United States | $1.152B | 0.00 |
| Aphria (APHA) | Canada | $1.130B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.060B | 21.13 |
| Cerus (CERS) | United States | $1.020B | 0.00 |
| MacroGenics (MGNX) | United States | $0.945B | 0.00 |
| InMode (INMD) | Israel | $0.937B | 19.80 |
| OraSure Technologies (OSUR) | United States | $0.902B | 181.75 |
| PetIQ (PETQ) | United States | $0.871B | 25.15 |
| Omeros (OMER) | United States | $0.811B | 0.00 |
| Quanterix (QTRX) | United States | $0.781B | 0.00 |
| DFB Healthcare Acquisitions (AHCO) | United States | $0.735B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.734B | 18.21 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.702B | 50.26 |
| Meridian Bioscience (VIVO) | United States | $0.662B | 24.93 |
| Zynex (ZYXI) | United States | $0.644B | 64.67 |
| Vapotherm (VAPO) | United States | $0.567B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.546B | 10.98 |
| LeMaitre Vascular (LMAT) | United States | $0.543B | 30.91 |
| Surmodics (SRDX) | United States | $0.503B | 60.62 |
| Owens & Minor (OMI) | United States | $0.500B | 13.22 |
| Repro-Med Systems (KRMD) | United States | $0.402B | 337.33 |
| Cytosorbents (CTSO) | United States | $0.370B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.362B | 26.32 |
| BioLife Solutions (BLFS) | United States | $0.336B | 149.54 |
| Viemed Healthcare (VMD) | United States | $0.321B | 28.72 |
| Organigram Holdings (OGI) | Canada | $0.306B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.283B | 0.00 |
| HEXO (HEXO) | $0.258B | 0.00 | |
| Female Health (VERU) | United States | $0.247B | 0.00 |
| Chimerix (CMRX) | United States | $0.193B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.169B | 0.00 |
| Evolus (EOLS) | United States | $0.154B | 0.00 |
| Fonar (FONR) | United States | $0.154B | 13.66 |
| Bovie Medical (APYX) | United States | $0.152B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.148B | 0.00 |
| Exagen (XGN) | United States | $0.146B | 0.00 |
| Surface Oncology (SURF) | United States | $0.145B | 0.00 |
| United Health Products (UEEC) | United States | $0.134B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.127B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.123B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.109B | 0.00 |
| Brainsway (BWAY) | Israel | $0.084B | 0.00 |
| Wound Management Technologies (SMTI) | United States | $0.074B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.073B | 0.00 |
| United-Guardian (UG) | United States | $0.072B | 16.77 |
| Nephros (NEPH) | United States | $0.070B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.066B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.045B | 0.00 |
| ImmuCell (ICCC) | United States | $0.033B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.030B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.025B | 0.00 |
| FSD PHARMA INC (HUGE) | Canada | $0.021B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.016B | 0.00 |
| Conatus Pharmaceuticals (HSTO) | United States | $0.014B | 0.00 |
| Senestech (SNES) | United States | $0.006B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.004B | 0.00 |
